Franklin Biotechnology Discovery Fund

Average Annual Total Returns [further-information] As of 12/31/2019

Month EndAs of 02/29/2020 1 Yr 3 Yr 5 Yr 10 Yr Since InceptionInception 09/15/1997
Fund without Sales Charge (%) (NAV) 8.59 4.70 0.64 15.32 10.99
Fund with Sales Charge (%) (POP) 8.59 4.70 0.64 15.32 10.99
NASDAQ Biotechnology Index (%) 1.18 4.88 0.31 15.22 11.33
S&P 500 Index (%) 8.19 9.87 9.23 12.65 7.34
Quarter EndAs of 12/31/2019 1 Yr 3 Yr 5 Yr 10 Yr Since InceptionInception 09/15/1997
Fund without Sales Charge (%) (NAV) 35.19 10.80 3.62 16.23 11.26
Fund with Sales Charge (%) (POP) 35.19 10.80 3.62 16.23 11.26
NASDAQ Biotechnology Index (%) 24.41 10.95 3.57 16.34 11.70
S&P 500 Index (%) 31.49 15.28 11.70 13.56 7.81

Calendar Year Returns

2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Fund without Sales Charge (%) (NAV) 35.19 -15.51 19.10 -16.96 5.75 34.28 69.15 29.72 8.65 17.64
Fund with Sales Charge (%) (POP) 35.19 -15.51 19.10 -16.96 5.75 34.28 69.15 29.72 8.65 17.64
NASDAQ Biotechnology Index (%) 24.41 -9.32 21.06 -21.68 11.42 34.32 65.97 32.29 12.08 15.25
S&P 500 Index (%) 31.49 -4.38 21.83 11.96 1.38 13.69 32.39 16.00 2.11 15.06

Cumulative Total Returns [further-information] As of 12/31/2019

Month EndAs of 02/29/2020 YTD 1 Yr 3 Yr 5 Yr 10 Yr Since Inception since 09/15/1997
Fund without Sales Charge (%) (NAV) -3.77 8.59 14.76 3.23 316.08 938.65
Fund with Sales Charge (%) (POP) -3.77 8.59 14.76 3.23 316.08 938.65
NASDAQ Biotechnology Index (%) -5.32 1.18 15.37 1.57 312.44 1,014.58
S&P 500 Index (%) -8.27 8.19 32.62 55.49 229.18 390.65
Quarter EndAs of 12/31/2019 YTD 1 Yr 3 Yr 5 Yr 10 Yr Since Inception since 09/15/1997
Fund without Sales Charge (%) (NAV) 35.19 35.19 36.04 19.46 349.93 979.29
Fund with Sales Charge (%) (POP) 35.19 35.19 36.04 19.46 349.93 979.29
NASDAQ Biotechnology Index (%) 24.41 24.41 36.56 19.17 353.96 1,077.15
S&P 500 Index (%) 31.49 31.49 53.17 73.86 256.66 434.87

After-Tax Average Annual Total Returns [further-information] As of 12/31/2019

Month EndAs of 02/29/2020 1 YR 3 YR 5 YR 10 YR
Fund without Sales Charge (%) (NAV) Before Shares Sold 6.44 3.40 -0.83 13.87
Fund without Sales Charge (%) (NAV) After Shares Sold 6.74 3.47 0.22 12.58
Fund with Sales Charge (%) (POP) Before Shares Sold 6.44 3.40 -0.83 13.87
Fund with Sales Charge (%) (POP) After Shares Sold 6.74 3.47 0.22 12.58
Quarter EndAs of 12/31/2019 1 YR 3 YR 5 YR 10 YR
Fund without Sales Charge (%) (NAV) Before Shares Sold 32.52 9.43 2.11 14.76
Fund without Sales Charge (%) (NAV) After Shares Sold 22.76 8.21 2.48 13.37
Fund with Sales Charge (%) (POP) Before Shares Sold 32.52 9.43 2.11 14.76
Fund with Sales Charge (%) (POP) After Shares Sold 22.76 8.21 2.48 13.37

SALES CHARGE, EXPENSES & FEES As of 09/01/2019 (updated annually)

Gross Expense Ratio 0.79%
Net Expense Ratio [further-information] 0.77%
Max Initial Sales Charge 0.00%
CDSC

Volatility Measures [further-information] As of 02/29/2020 Updated Monthly, based on a 3-year period

Beta 1.04
Sharpe Ratio 0.14
Standard Deviation 22.15

Benchmarks

A benchmark is a comparable broad-based index that can be used to evaluate a fund's performance.

  • NASDAQ Biotechnology Index
  • S&P 500 Index